Loading...

ADGM ADAGIO MEDICAL HOLDINGS INC Expansion Plans 8-K Filing

DG M

DGM

ADAGIO MEDICAL HOLDINGS INC

(ADGM)

2025 8-K

Financial Results Update

Annual Meeting Results

Quarterly Results

Annual Meeting Announcement

Private Placement Closed

Securities Agreement

Study Results Released

Enrollment Complete

CFO Appointment

Financial Update

Financial Statements

Financial Results

CFO Resignation

Management Change

Corporate Restructuring

Agreement Termination

Compliance Waiver

Director Resignation

Financial Results

Financial Restatement

Financial Restatement

External Links:

On October 10, 2025, Adagio Medical Holdings, Inc. announced preliminary safety and efficacy results from its FULCRUM-VT Study on Ultralow Temperature Cryoablation technology for treating Sustained Monomorphic Ventricular Tachycardia. The results were presented at an international symposium the same day.

AI Assistant

ADAGIO MEDICAL HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.